Identifying Patients at Greatest Risk of Mortality due to COVID-19: A New England Perspective (vol 21, pg 785, 2020)

被引:0
|
作者
Smith, Aaron A. [1 ]
Fridling, Jeremy [1 ]
Ibrahim, Danyal [2 ]
Porter, Paul S., Jr. [2 ]
机构
[1] Quinnipiac Univ, Frank H Netter MD Sch Med, North Haven, CT USA
[2] St Marys Hosp, Trinity Hlth New England, Waterbury, CT USA
关键词
D O I
10.5811/westjem.2020.9.50059
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Introduction: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly since December 2019, resulting in a pandemic that has, as of May 24, 2020, yielded over 5.3 million confirmed cases and over 340,000 deaths.(1) As businesses move to safely reopen and frontline healthcare workers (HCW) continue to face this crisis, it is essential that health officials know who in the population is at the greatest risk of mortality if hospitalized and, therefore, has the greatest need to protect themselves from being infected. We examined the factors that increase the risk of mortality among hospitalized COVID-19 patients. Methods: This was a retrospective cohort study including confirmed COVID-19 patients admitted to the four Trinity Health of New England hospitals (THONE) in Connecticut and Massachusetts who either died or were discharged between March 1-April 22, 2020. Demographics, comorbidities, and outcomes of care were extracted from the electronic health record. A model of in-hospital mortality was made using a generalized linear model with binomial distribution and log link. Results: The analysis included 346 patients: 229 discharged and 117 deceased. The likelihood of in-hospital mortality was increased for patients who were aged 60 or older (relative risk [RR] = 2.873; 95% confidence interval [CI], 1.733-4.764; p = <0.001), had diabetes (RR = 1.432; 95% CI,1.068-1.921; p = 0.016), or had chronic obstructive pulmonary disease (COPD) (RR = 1.410; 95% CI, 1.058-1.878; p = 0.019). Hyperlipidemia had a protective effect, reducing the likelihood of mortality (RR = 0.745; 95% CI, 0.568-0.975; p = 0.032). Sensitivity and specificity of the model were 51.4% and 88.4%, respectively. Conclusions: Being age 60 or older or having a history of diabetes or COPD are the most useful risk factors associated with mortality in hospitalized COVID-19 patients. As states ease stay-at-home orders, risk factors of severe disease can be used to identify those more likely to have worse outcomes if infected and hospitalized and, therefore, who in particular should continue to follow public health guidelines for avoiding infection: stay home if possible; practice physical distancing; and wear a facemask.
引用
收藏
页码:295 / 295
页数:1
相关论文
共 50 条
  • [1] Identifying Patients at Greatest Risk of Mortality due to COVID-19: A New England Perspective
    Smith, Aaron A.
    Fridling, Jeremy
    Ibhrahim, Danyal
    Porter, Paul S., Jr.
    WESTERN JOURNAL OF EMERGENCY MEDICINE, 2020, 21 (04) : 785 - 789
  • [2] COVID-19: A Risk Assessment Perspective (vol 27, pg 160, 2020)
    Schroeder, Imke
    ACS CHEMICAL HEALTH & SAFETY, 2020, 27 (05) : 308 - 308
  • [3] Obesity predisposes to the risk of higher mortality in young COVID-19 patients (vol 92, pg 2536, 2020)
    Zhang, Fengqin
    Wei, Yanqiu
    Liu, Kui
    Xiong, Ying
    Zhu, Wenzhen
    JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (01) : 576 - 576
  • [5] Transmission risk of patients with COVID-19 meeting discharge criteria should be interpreted with caution (vol 21, pg 408, 2020)
    Su, Jun-wei
    Wu, Wen-rui
    Lang, Guan-jing
    Zhao, Hong
    Sheng, Ji-fang
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2020, 21 (09): : 755 - 755
  • [6] Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? (vol 8, pg e21, 2020)
    Fang, L.
    Karakiulakis, G.
    Roth, M.
    LANCET RESPIRATORY MEDICINE, 2020, 8 (06): : E54 - E54
  • [7] Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21
    Wang, Haidong
    Paulson, Katherine R.
    Pease, Spencer A.
    Watson, Stefanie
    Comfort, Haley
    Zheng, Peng
    Aravkin, Aleksandr Y.
    Bisignano, Catherine
    Barber, Ryan M.
    Alam, Tahiya
    Fuller, John E.
    May, Erin A.
    Jones, Darwin Phan
    Frisch, Meghan E.
    Abbafati, Cristiana
    Adolph, Christopher
    Allorant, Adrien
    Amlag, Joanne O.
    Bang-Jensen, Bree
    Bertolacci, Gregory J.
    Bloom, Sabina S.
    Carter, Austin
    Castro, Emma
    Chakrabarti, Suman
    Chattopadhyay, Jhilik
    Cogen, Rebecca M.
    Collins, James K.
    Cooperrider, Kimberly
    Dai, Xiaochen
    Dangel, William James
    Daoud, Farah
    Dapper, Carolyn
    Deen, Amanda
    Duncan, Bruce B.
    Erickson, Megan
    Ewald, Samuel B.
    Fedosseeva, Tatiana
    Ferrari, Alize J.
    Frostad, Joseph Jon
    Fullman, Nancy
    Gallagher, John
    Gamkrelidze, Amiran
    Guo, Gaorui
    He, Jiawei
    Helak, Monika
    Henry, Nathaniel J.
    Hulland, Erin N.
    Huntley, Bethany M.
    Kereselidze, Maia
    Lazzar-Atwood, Alice
    LANCET, 2022, 399 (10334): : 1513 - 1536
  • [8] Endocrine and metabolic aspects of the COVID-19 pandemic (vol 21, pg 495, 2020)
    Marazuela, Monica
    Giustina, Andrea
    Puig-Domingo, Manuel
    REVIEWS IN ENDOCRINE & METABOLIC DISORDERS, 2021, 22 (01): : 145 - 145
  • [9] New Insights Into the Seriousness of Acute Myocardial Injury During COVID-19 (vol 21, pg 328, 2020)
    Alderighi, Camilla
    Rasoini, Raffaele
    Ambrosio, Giuseppe
    Valente, Serafina
    Gensini, Gian Franco
    GIORNALE ITALIANO DI CARDIOLOGIA, 2020, 21 (06) : 478 - 478
  • [10] Identifying Patients at Risk of Delayed Breast Imaging Due to the COVID-19 Pandemic
    Li, Shiyi
    O'Brien, Sophia
    Murphy, Christina
    Nabil, Calisi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (08)